Medicare Enrolled
Dr. Irina Shpak, MD
Critical Care Medicine · Bethpage, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shpak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shpak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shpak
Dr. Irina Shpak is a critical care medicine specialist in Bethpage, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shpak performed 2,811 Medicare services across 1,937 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shpak received a total of $20,686 from 55 pharmaceutical and/or device companies across 646 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shpak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in NY
$20,686 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,811
Medicare services
Top 6% in NY for critical care medicine
1,937
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~141 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
635 | $111 | $406 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
358 | $74 | $270 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
312 | $199 | $735 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
270 | $117 | $442 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
206 | $161 | $591 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
201 | $52 | $193 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
201 | $54 | $202 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
201 | $76 | $313 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
193 | $26 | $96 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $153 | $579 |
| Chest X-ray, 1 view An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity. |
39 | $26 | $94 |
| Lung airway biopsy using endoscope A procedure to remove a small tissue sample from the lung airways using a flexible tube with a camera. The sample is examined to check for disease or abnormalities. |
29 | $113 | $530 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
26 | $37 | $138 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
25 | $5 | $457 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $122 | $447 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
17 | $102 | $373 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $36 | $85 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
15 | $75 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,686
Total received (2018-2024)
Avg $2,955/year across 7 years
Top 7% in NY for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
646
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,606 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59 (0.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,524
2023
$3,134
2022
$2,424
2021
$3,046
2020
$2,138
2019
$2,189
2018
$2,231
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$2,270
Noah Medical Corporation
$722
AstraZeneca Pharmaceuticals LP
$556
GlaxoSmithKline, LLC.
$184
Siemens Medical Solutions USA, Inc.
$165
Olympus America Inc.
$144
Regeneron Healthcare Solutions, Inc.
$142
Boehringer Ingelheim Pharmaceuticals, Inc.
$142
Mylan Specialty L.P.
$136
UCB, Inc.
$125
Electromed, Inc.
$121
Novartis Pharmaceuticals Corporation
$118
GENZYME CORPORATION
$89
Baxter Healthcare
$77
Galvanize Therapeutics, Inc
$75
Actelion Pharmaceuticals US, Inc.
$70
Chiesi USA, Inc.
$59
Philips North America LLC
$58
Merck Sharp & Dohme LLC
$58
Grifols USA, LLC
$43
Mallinckrodt Hospital Products Inc.
$32
ANI Pharmaceuticals, Inc.
$26
Insmed, Inc.
$24
INOGEN, INC.
$23
Paratek Pharmaceuticals, Inc.
$19
ABBVIE INC.
$18
PFIZER INC.
$14
Genentech USA, Inc.
$13
Top 3 companies account for 64.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,714
INTUITIVE SURGICAL, INC.
$2,270
AstraZeneca Pharmaceuticals LP
$2,206
Ethicon Inc.
$1,995
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,550
GENZYME CORPORATION
$783
Noah Medical Corporation
$722
Actelion Pharmaceuticals US, Inc.
$715
Sunovion Pharmaceuticals Inc.
$680
Regeneron Healthcare Solutions, Inc.
$613
Mylan Specialty L.P.
$550
Philips Electronics North America Corporation
$483
Novartis Pharmaceuticals Corporation
$411
Genentech USA, Inc.
$387
Electromed, Inc.
$317
Mallinckrodt Hospital Products Inc.
$267
Regeneron Pharmaceuticals, Inc.
$261
Baxter Healthcare
$259
Alexion Pharmaceuticals, Inc.
$236
Grifols USA, LLC
$209
Galvanize Therapeutics, Inc
$202
Amgen Inc.
$191
Mallinckrodt Enterprises LLC
$184
Insmed, Inc.
$168
Siemens Medical Solutions USA, Inc.
$165
Covidien LP
$154
Teva Pharmaceuticals USA, Inc.
$148
La Jolla Pharmaceutical Company
$148
Olympus America Inc.
$144
Medtronic, Inc.
$127
UCB, Inc.
$125
Pulmonx Corporation
$125
Ethicon US, LLC
$114
PFIZER INC.
$108
Chiesi USA, Inc.
$106
Merck Sharp & Dohme LLC
$101
Intuitive Surgical, Inc.
$98
Cumberland Pharmaceuticals, Inc.
$84
Inogen, Inc.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$74
Philips North America LLC
$58
Advanced Respiratory, Inc
$52
SANOFI-AVENTIS U.S. LLC
$46
Shionogi Inc
$37
ANI Pharmaceuticals, Inc.
$26
Otsuka America Pharmaceutical, Inc.
$24
INOGEN, INC.
$23
Itamar Medical Inc
$22
BOSTON SCIENTIFIC CORPORATION
$22
Phadia US Inc.
$20
Boston Scientific Corporation
$20
Paratek Pharmaceuticals, Inc.
$19
ABBVIE INC.
$18
Janssen Pharmaceuticals, Inc
$13
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 34.8% of all-time payments
Associated products mentioned in payments ›
(1305) Mask · (8874) inCourage · (AK6) Vest Therapy · ACQUIRE · ACTHAR · AIRSUPRA · ALIYA SYSTEM · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRIDION · BROVANA · CALDOLOR · CAPVAXIVE · CINQAIR · CLEVIPREX · Caldolor · Cios Spin · CoreDx · DALVANCE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · Dymista · ELIQUIS · Edge Navigation · Esbriet · FARXIGA · FASENRA · Fetroja · GALAXY · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - VisiVest Airway Clearance System · INOGEN AT HOME STATIONARY CONCENTRATOR · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ImmunoCAP · LINX Reflux Management System · LONHALA MAGNAIR · Monarch Platform · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Respiratoriy Care Undiv · Rystiggo · SAMSCA · SEEBRI · SMARTVEST · SPIRIVA RESPIMAT · SPiN Vision Video Processor · STIOLTO RESPIMAT · SYMBICORT · Soliris · TEZSPIRE · TRELEGY ELLIPTA · The VisiVest Airway Clearance System · ULTOMIRIS · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · WatchPAT · Wellcentive Undiv · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for critical care medicine in NY.
Geographic Context
Critical care medicines within 10 mi
254
Per 100K population
18.3
County median income
$143,408
Nearest hospital
CHSLI ST JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shpak is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NY), with low-engagement industry engagement in the top 7% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shpak experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Shpak performed 635 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shpak receive payments from pharmaceutical companies?
Yes. Dr. Shpak received a total of $20,686 from 55 companies across 646 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shpak's costs compare to other critical care medicines in Bethpage?
Dr. Shpak's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shpak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Bethpage
Browse critical care medicines in Bethpage ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in NY
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in NY
Which NY critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology